214 related articles for article (PubMed ID: 12894505)
1. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G
Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505
[TBL] [Abstract][Full Text] [Related]
2. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
Samadder P; Arthur G
Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
[TBL] [Abstract][Full Text] [Related]
3. 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells.
Zhou X; Lu X; Richard C; Xiong W; Litchfield DW; Bittman R; Arthur G
J Clin Invest; 1996 Aug; 98(4):937-44. PubMed ID: 8770865
[TBL] [Abstract][Full Text] [Related]
4. ET-18-OCH3 inhibits the phosphorylation and activation of p70 S6 kinase in MCF-7 cells.
Arthur G; Samadder P; Bittman R
Anticancer Res; 2005; 25(1A):95-100. PubMed ID: 15816524
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization.
Kosano H; Takatani O
Cancer Res; 1989 Jun; 49(11):2868-70. PubMed ID: 2785846
[TBL] [Abstract][Full Text] [Related]
6. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
Zhou X; Lu X; Arthur G
Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233
[TBL] [Abstract][Full Text] [Related]
7. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
[TBL] [Abstract][Full Text] [Related]
9. The antitumor ether lipid edelfosine (ET-18-O-CH3) induces apoptosis in H-ras transformed human breast epithelial cells: by blocking ERK1/2 and p38 mitogen-activated protein kinases as potential targets.
Na HK; Surh YJ
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():204-7. PubMed ID: 18296338
[TBL] [Abstract][Full Text] [Related]
10. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
Kosano H; Takatani O
Cancer Res; 1988 Nov; 48(21):6033-6. PubMed ID: 3262419
[TBL] [Abstract][Full Text] [Related]
11. Association of Grb2 with Sos and Ras with Raf-1 upon gamma irradiation of breast cancer cells.
Suy S; Anderson WB; Dent P; Chang E; Kasid U
Oncogene; 1997 Jul; 15(1):53-61. PubMed ID: 9233777
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O
Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
[TBL] [Abstract][Full Text] [Related]
15. Cell kill and cytostasis by ET-18-OCH3 and heat.
Fujiwara K; Modest EJ; Wallen CA
Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
[TBL] [Abstract][Full Text] [Related]
16. Membrane recruitment of Raf-1 is not the only function of Ras in Raf-1 activation.
Tamada M; Hu CD; Kariya K; Okada T; Kataoka T
Oncogene; 1997 Dec; 15(24):2959-64. PubMed ID: 9416839
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis.
Alonso MT; Gajate C; Mollinedo F; Modolell M; Alvarez J; García-Sancho J
Br J Pharmacol; 1997 Aug; 121(7):1364-8. PubMed ID: 9257915
[TBL] [Abstract][Full Text] [Related]
18. Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation.
Sippel RS; Chen H
Surgery; 2002 Dec; 132(6):1035-9; discussion 1039. PubMed ID: 12490852
[TBL] [Abstract][Full Text] [Related]
19. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities.
Kanno N; Lesage G; Phinizy JL; Glaser S; Francis H; Alpini G
Hepatology; 2002 Jun; 35(6):1329-40. PubMed ID: 12029618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
